SMMT vs. AXON
SMMT (Summit Therapeutics Inc.) and AXON (Axon Enterprise, Inc.) are both stocks. SMMT operates in Biotechnology (Healthcare), while AXON operates in Aerospace & Defense (Industrials). Over the past 10 years, SMMT returned 5.31%/yr vs 34.58%/yr for AXON. At a 0.10 correlation, their price movements are largely independent.
Performance
SMMT vs. AXON - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMMT achieves a -19.90% return, which is significantly higher than AXON's -22.22% return. Over the past 10 years, SMMT has underperformed AXON with an annualized return of 5.31%, while AXON has yielded a comparatively higher 34.58% annualized return.
SMMT
- 1D
- 7.11%
- 1M
- -25.44%
- YTD
- -19.90%
- 6M
- -20.26%
- 1Y
- -30.51%
- 3Y*
- 93.96%
- 5Y*
- 15.49%
- 10Y*
- 5.31%
AXON
- 1D
- -1.00%
- 1M
- 17.23%
- YTD
- -22.22%
- 6M
- -21.72%
- 1Y
- -43.02%
- 3Y*
- 30.96%
- 5Y*
- 22.92%
- 10Y*
- 34.58%
SMMT vs. AXON - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics Inc. | -19.90% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 39.13% | -89.62% | 29.44% |
AXON Axon Enterprise, Inc. | -22.22% | -4.44% | 130.06% | 55.69% | 5.69% | 28.13% | 67.21% | 67.50% | 65.09% | 9.32% |
Correlation
The correlation between SMMT and AXON is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Mar 5, 2015 | 0.10 |
Fundamentals
SMMT:
$10.86B
AXON:
$36.43B
SMMT:
-$1.60
AXON:
$2.41
SMMT:
19.90
AXON:
10.31
SMMT:
$0.00
AXON:
$2.98B
SMMT:
-$83.36K
AXON:
$1.77B
SMMT:
-$738.34M
AXON:
$156.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMMT vs. AXON — Risk / Return Rank
SMMT
AXON
SMMT vs. AXON - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and Axon Enterprise, Inc. (AXON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMMT | AXON | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.37 | ||
| Sortino ratioReturn per unit of downside risk | +0.91 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 0.87 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.55 | -0.72 | +0.16 |
| Martin ratioReturn relative to average drawdown | -0.87 | -1.22 | +0.34 |
Loading charts...
Drawdowns
SMMT vs. AXON - Drawdown Comparison
The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum AXON drawdown of -91.78%. Use the drawdown chart below to compare losses from any high point for SMMT and AXON.
Loading charts...
Drawdown Indicators
| SMMT | AXON | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.75% | -91.78% | -3.97% |
Max Drawdown (1Y)Largest decline over 1 year | -55.49% | -60.28% | +4.79% |
Max Drawdown (3Y)Largest decline over 3 years | -64.44% | -60.28% | -4.16% |
Max Drawdown (5Y)Largest decline over 5 years | -91.78% | -60.28% | -31.50% |
Max Drawdown (10Y)Largest decline over 10 years | -95.75% | -60.28% | -35.47% |
Current DrawdownCurrent decline from peak | -61.83% | -49.28% | -12.55% |
Average DrawdownAverage peak-to-trough decline | -57.63% | -43.60% | -14.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.94% | 35.34% | -0.40% |
Volatility
SMMT vs. AXON - Volatility Comparison
Summit Therapeutics Inc. (SMMT) has a higher volatility of 23.99% compared to Axon Enterprise, Inc. (AXON) at 17.73%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than AXON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMMT | AXON | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.99% | 17.73% | +6.26% |
Volatility (6M)Calculated over the trailing 6-month period | 56.65% | 44.20% | +12.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.61% | 55.66% | +19.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 185.08% | 47.94% | +137.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 144.46% | 49.18% | +95.28% |
Dividends
SMMT vs. AXON - Dividend Comparison
Neither SMMT nor AXON has paid dividends to shareholders.
Financials
SMMT vs. AXON - Financials Comparison
This section allows you to compare key financial metrics between Summit Therapeutics Inc. and Axon Enterprise, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SMMT and AXON have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMMT has higher volatility (23.99%) compared to AXON (17.73%). In terms of maximum drawdown, SMMT dropped -95.75% vs AXON's -91.78%.
SMMT currently has the higher Sharpe Ratio (-0.41 vs -0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMMT and AXON
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer